Delivery Order SPE2DR25D1053-SPE2DR26FU403
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,877.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's role as a major...
- The Defense Logistics Agency awarded a delivery order valued at $39,616.92 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment...
- The Defense Logistics Agency awarded a delivery order valued at $9,418.24 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, non-set-aside delivery order is scheduled for completion by August 8, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,973.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $6,972.88 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $20,526.67 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical supplier's role in supporting...
- The Defense Logistics Agency awarded a $27,762.83 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the agency's ongoing procurement of pharmaceutical products to...
- The Defense Logistics Agency awarded a delivery order valued at $4,147.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count supply) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication indicated for migraine treatment, reflecting the...
- The Defense Logistics Agency awarded a $37,622.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine in adults and represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $3,952.70 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8 count) on October 30, 2025, with completion scheduled for October 31, 2025. This is a firm fixed-price, non-set-aside contract that will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical supply needs of federal military and healthcare systems. This...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FU403Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,993.19 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 4, 2025, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a prescription migraine treatment, reflecting the pharmaceutical supply needs within the federal medical procurement system. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999 million through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical requirements through open competition and its substantial prime IDV position establish it as a key supplier supporting the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/3/25 |